Voya Financial Advisors’s Charles River Laboratories CRL Stock Holding History

Voya Financial Advisors’s Portfolio CRL Stock Details CRL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-939	Closed	-$253K	–	233
2024 Q1	$253K	Sell	939 -35	-4%	-$8.36K	0.03%	212
2023 Q4	$233K	Buy	+974	New	+$192K	0.03%	214
2023 Q3	–	Sell	-988	Closed	-$207K	–	229
2023 Q2	$207K	Buy	+988	New	+$197K	0.02%	226
2023 Q1	–	Sell	-1,149	Closed	-$257K	–	237
2022 Q4	$257K	Sell	1,149 -384	-25%	-$83.9K	0.03%	198
2022 Q3	$291K	Buy	1,533 +39	+3%	+$8.42K	0.04%	187
2022 Q2	$328K	Sell	1,494 -234	-14%	-$57.2K	0.04%	179
2022 Q1	$501K	Buy	+1,728	New	+$533K	0.06%	161

Other funds holding CRL

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Meritage Group San Francisco, California $2.6B AUM 15.71% 1-Year Est. Return

SCA

Southpoint Capital Advisors New York $4.4B AUM 49.36% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return

Voya Financial Advisors's CRL Position: Q2 2024 in Review

Voya Financial Advisors sold out of Charles River Laboratories (CRL) in Q2 2024, closing a stake of 939 shares — an estimated $253K sold.

Voya Financial Advisors first reported a position in CRL in Q1 2022 and held it in 7 quarters. The position peaked at $501K in Q1 2022. 665 funds tracked by Wall St. Rank hold CRL as of Q2 2024.

Voya Financial Advisors reported no remaining Charles River Laboratories position as of Q2 2024 after selling out during the quarter.
Voya Financial Advisors sold 939 Charles River Laboratories shares in Q2 2024, an estimated $253K.
Voya Financial Advisors first reported a position in Charles River Laboratories in Q1 2022 and held it in 7 quarters.
Voya Financial Advisors's Charles River Laboratories position peaked at $501K in Q1 2022.
665 funds tracked by Wall St. Rank held Charles River Laboratories as of Q2 2024.

Based on Voya Financial Advisors's 13F filing for Q2 2024, filed 14 Aug 2024.